Boston Globe - Last week we picked up rib-eyes from six markets around Boston: Costco Wholesale , John Dewar & Company, Roche Bros., Shaw’s, Stop & Shop, and Whole Foods Market . We stopped by without placing any orders, looking for basic steaks, nothing prime
Nikkei hits 3-week low, exporters, chip shares fall
Reuters India - Ltd., the Japanese drug maker half-owned by Switzerland’s Roche Holding AG, said it would buy back up to 28 billion yen ($233 million) worth of its own shares from Feb. 8 to March 23. The maximum 9.5 million shares would account for 1.70 percent of
Roche Starts 2007 With 47 Phase III Projects - Executive -2-
Beurs.nl - Burns, speaking to analysts during a conference call to detail the company’s 2006 financial results, said Roche expected to file a marketing approval application for its rheumatoid arthritis drug Actemra with regulators around the world in late 2007
European indices open positive
MyIris - Roche fell after the world`s biggest maker of medicines reported earnings that missed analyst expectations. The French benchmark index was seen trading higher by 16.80 points, or 0.30%, at 5693.58, and UK`s FTSE CAC 40 advanced 10.00 points, or 0
Drugmaker Roche boosting spending on research and development
Newsday - BASEL, Switzerland — Drugmaker Roche Holding AG said Monday it would increase its spending on research and development this year, partly through the creation of two new units based in the United States. The Swiss-based pharmaceutical company, whose
Swiss shares flat in afternoon as Roche weakness offsets early Wall St
Forbes - ZURICH (AFX) - Share prices were unchanged in quiet afternoon trade, as a higher opening on Wall Street following positive economics data was offset by continued weakness in heavyweight pharma stock Roche, dealers said. At 3.35 pm, the Swiss Market
FTC limits Rambus royalties
San Diego Union-Tribune - Roche to spend more on research Drugmaker Roche Holding AG said it would increase its spending on research and development this year, partly through the creation of two new units based in the United States. A cancer drugs unit will be based in

